The Online Investor
PROLOR Biotech, Inc. (PBTH)

PROLOR Biotech is a development stage biopharmaceutical company utilizing patented technology to develop versions of already-approved therapeutic proteins. Co. has obtained certain worldwide rights from Washington University in St. Louis, MO to use an amino acid sequence (peptide) that has the effect of slowing the removal from the body of the therapeutic protein to which it is attached. As of Dec. 31, 2011, Co. engaged in the development and commercialization of six products: Human Growth Hormone, Factor IX, anti-obesity peptide Oxyntomodulin, Factor VIIa, Interferon , Erythropoietin, and anti-atherosclerosis and rheumatoid arthritis therapeutics.
Company Name: 
PROLOR Biotech, Inc.
Quotes delayed 20 minutes

Email EnvelopeFree PBTH Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Strong Buy (4.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

PROLOR Biotech, Inc. (PBTH) Page | The Online Investor Page |

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.